URICA THERAPEUTICS
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases. Urica is a subsidiary company of Fortress Biotech.
URICA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.uricatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
2.53 M USD
Similar Organizations
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Official Site Inspections
http://www.uricatherapeutics.com
- Host name: cust-155.130.138.30.switch.com
- IP address: 155.130.138.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Urica Therapeutics"
About Us – Urica Therapeutics
Urica is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout.See details»
Urica Therapeutics - Crunchbase Company Profile & Funding
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases.See details»
Urica Therapeutics, Inc. | LinkedIn
Urica Therapeutics, Inc. (“Urica”) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other ...See details»
Management Team – Urica Therapeutics
24 years as CEO of 2 public companies (with 2 rheumatology product approvals), and most recently led Pfizer’s External R&D Innovation group and R&D Innovate venture fundSee details»
Urica Therapeutics - Products, Competitors, Financials, Employees ...
Uricatherapeutics.com. Overview & Products; Financials; People; Founded Year 2022. Stage Seed | Alive. Total Raised $2.53M. Last Raised $2.53M | 2 yrs ago. About Urica Therapeutics. …See details»
Urica Therapeutics - PitchBook
Www.uricatherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 1111 Kane Concourse; Suite 301; Bay Harbor …See details»
Urica Therapeutics - VentureRadar
Website: https://uricatherapeutics.com/ Urica is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical ...See details»
Urica Therapeutics Company Profile | Management and ... - Datanyze
Www.uricatherapeutics.com Urica Therapeutics Profile and History Urica Therapeutics, Inc. ("Urica") is a clinical-stage biopharmaceutical company that focuses on the development and …See details»
Urica Therapeutics - Work in biotech
Urica Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for gout and other conditions associated with hyperuricemia. Their lead …See details»
Board of Directors – Urica Therapeutics
Currently also Chairman, President, and CEO at Fortress Biotech (NASDAQ: FBIO) Previously Founder/Board Member of multiple biotech companies: Cougar Biotechnology (acquired by …See details»
Urica Therapeutics, Inc. Overview | SignalHire Company Profile
Urica Therapeutics, Inc. (“Urica”) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other …See details»
News / Events - Fortress Biotech, Inc.
Jun 29, 2023 For more information, please visit www.uricatherapeutics.com. About Fortress Biotech Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company …See details»
Urica Therapeutics | Pharmaceutical - The Pharmaletter
A clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and chronic kidney disSee details»
Urica Therapeutics - Overview, News & Similar companies
Who is Urica Therapeutics. Urica Therapeutics, Inc. ("Urica") is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceu tical products …See details»
Investors & Media – Urica Therapeutics
Urica Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and chronic …See details»
NIH-funded study identifies potential new stroke treatment
Mar 17, 2025 About the National Institute of Neurological Disorders and Stroke (NINDS): NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of …See details»
Urica Therapeutics Announces Topline Data from the Phase 1 …
Jun 29, 2023 Jay D. Kranzler, M.D., Ph.D., Urica’s Chairman and Chief Executive Officer, said, “We are encouraged that the data from our Phase 1 clinical trial in U.S. healthy volunteers …See details»
Corporate Presentation – Urica Therapeutics
Check back soon for updates. 2023 URICA THERAPEUTICS. ALL RIGHTS RESERVED. PRIVACY POLICY. Scroll to topSee details»
Urica Therapeutics-动脉网 - vbdata.cn
Jan 1, 2021 Urica Therapeutics, Inc.（简称“Urica”）是一家临床阶段的生物制药公司，专注于开发和商业化治疗痛风和其他与高尿酸血症相关疾病的药品。Urica从Fuji Yakuhin公司获得了在 …See details»
Company Overview - Urica Therapeutics
Lead Asset –Dotinurad •Dotinurad is approved in Japan for hyperuricemia with or without gout1,2 •Japanese approval is based on 1000+ subjects treated in 17 clinical trials •500+ patients …See details»